Arrowhead Pharmaceuticals' SWOT analysis: stock poised for potential breakthrough
Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR), a biopharmaceutical company with a market capitalization of $2.68 billion ...
2,020 Shares in Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) Purchased by R Squared Ltd
R Squared Ltd acquired a new stake in Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR – Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The ...
bovnews8d
The ARWR Conundrum: Why Arrowhead Pharmaceuticals Inc’s Stock Is Making Headlines Again
Arrowhead Pharmaceuticals Inc (ARWR) stock saw a decline, ending the day at $20.76 which represents a decrease of $-0.77 or -3.58% from the prior close of $21.53. The stock opened at $21.23 and ...
bovnews10d
Why Did Arrowhead Pharmaceuticals Inc (ARWR) Stock See 5.08% Surge in the Last 90 Days?
Arrowhead Pharmaceuticals Inc (ARWR) stock saw a modest uptick, ending the day at $21.53 which represents a slight increase of $1.82 or 9.23% from the prior close of $19.71. The stock opened at $20.05 ...